Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1997-04-15
2000-08-15
Hutzell, Paula K.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
4241841, A61K 39395, A61K 3900
Patent
active
061032352
ABSTRACT:
Provided is a method of treating an immune system disorder not involving T cell proliferation, comprising administering to the animal an immunotoxin comprising a mutant diphtheria toxin moiety linked to an antibody moiety which routes by the anti-CD3 pathway, or derivatives thereof under conditions such that the disorder is treated. Thus, the present method can treat graft-versus-host disease. Also provided is a method of inhibiting a rejection response by inducing immune tolerance in a recipient to a foreign mammalian donor tissue or cells, comprising the steps of: a) exposing the recipient to an immunotoxin so as to reduce the recipients's peripheral blood T-cell lymphocyte population by at least 80%, wherein the immunotoxin is anti-CD3 antibody linked to a diphtheria protein toxin, wherein the protein has a binding site mutation; and b) transplanting the donor cells into the recipient, whereby a rejection response by the recipient to the donor organ cell is inhibited, and the host is tolerized to the donor cell.
REFERENCES:
patent: 5167956 (1992-12-01), Neville, Jr.
Ma, et al. Expression and Characterization of a Divalent Chimeric Anti-Human CD3 Single Chain Antibody Scand. J. Immunol. 43, 134-139, 1996.
Lu et al (J. Am. Soc. Neprol., 4:1239-1256, 1993.
Nemoto et al (Agents Actions, 36:306-311, 1992.
Koehler et al (Bone Marrow Transplantation, 13:571-575, 1994.
Neville et al. J. Immunotherapy 19(2):85-92, 1996.
Thompson et al. J. Biol. Chem. 270(47):28037-28041, Nov. 24, 1995.
Neville et al. J. Controlled Release 24(1-3):133-144, May 1993.
Neville et al. Proc. Natl. Acad. Sci. USA 89:2585-2589, 1992.
Pastan et al. Science 254:1173-1177, Nov. 22, 1991.
Parlevliet et al. Transplantation 50:889-892, Nov., 1990.
Kappler et al. Science 244:811-813, May 19, 1989.
Greenfield et al. Science 238:536-539, 1987.
Nooij and Jonker Eur. J. Immunol. 17:1089-1093, 1987.
Thomas et al. Transplantation (1994) 57:101-115.
Thomas et al. Transplantation Proceedings (1995) 27:3167.
Traunecker, et al. Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. The EMBO Journal (1)12:3655-3659 (1991).
Hayden et al. Single-chain mono-and bispecific antibody derivatives with novel biological properties and antitumor activity from a COS cell transient expression system. Therapeutic Immunology(1):3-15 (1994).
Knechtle Stuart
Neville David M.
Hutzell Paula K.
The UAB Research Foundation
The United States of America as represented by the Department of
Ungar Susan
LandOfFree
Methods of inducing immune tolerance using immunotoxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inducing immune tolerance using immunotoxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inducing immune tolerance using immunotoxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2003728